Market cap
₹16 Cr
Revenue (TTM)
₹168 Cr
P/E Ratio
45
P/B Ratio
0.5
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹3 Cr
-
ROE
10.5 %
-
ROCE
11 %
-
Industry P/E
39.7
-
EV/EBITDA
17.2
-
Debt to Equity
1.7
-
Book Value
₹17.7
-
EPS
₹1.7
-
Face value
10
-
Shares outstanding
17,668,564
Years Aggregate
CFO
₹--
EBITDA
₹--
Net Profit
₹--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Mono Pharmacare
| -40.8 | -9.5 | -27.7 | -60.0 | -31.5 | -- | -- |
|
BSE Healthcare
| 18.7 | 1.7 | 10.2 | 18.2 | 22.8 | 14.5 | 12.3 |
|
Company
|
2025
|
2024
|
|---|---|---|
|
Mono Pharmacare
| -53.9 | -31.7 |
|
BSE Small Cap
| -6.6 | 29.0 |
|
BSE Healthcare
| -3.3 | 43.1 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Mono Pharmacare
|
9.0 | 15.9 | 168.3 | 3.1 | -- | 10.5 | 45 | 0.5 |
| 3,160.6 | 25,815.6 | 1,461.8 | 387.4 | 34.5 | 25.2 | 66.8 | 14.9 | |
| 834.9 | 16,429.7 | 7,784.0 | 688.5 | 10.6 | 14 | 23.7 | 2.8 | |
| 456.0 | 17,456.0 | 2,141.5 | 58.5 | 5.8 | 3.3 | 164.3 | 4.5 | |
| 828.5 | 20,518.8 | 5,632.3 | 662.4 | 17.2 | 14.3 | 31 | 4.2 | |
| 1,519.1 | 17,370.7 | 1,543.3 | -48.6 | 3.6 | -0.6 | -- | 3.0 | |
| 214.4 | 28,550.8 | 9,205.3 | -371.8 | 1.7 | -3.8 | -- | 3.6 | |
| 1,819.6 | 30,087.9 | 1,935.8 | 288.2 | 20.6 | 29.8 | 104.4 | 22.4 | |
| 400.8 | 16,183.1 | 3,600.2 | 221.0 | 9.7 | 5.6 | 73.2 | 3.4 | |
| 1,883.7 | 30,606.2 | 3,564.0 | 414.0 | 15.3 | 8.4 | 74.8 | 6.1 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Mono Pharmacare
Manufacture of pharmaceuticals, medicinal chemical and botanical products
-
Incorporated
2022
-
Chairman
--
-
Managing Director
Panilam Lakhatariya
-
Headquarters
Ahmedabad, Gujarat
-
Website
Looking for more details about Mono Pharmacare Ltd’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Mono Pharmacare
What is the current share price of Mono Pharmacare Ltd Today?
The share price of Mono Pharmacare Ltd is ₹9.00 (NSE) as of 31-Aug-2026 IST. Mono Pharmacare Ltd has given a return of -31.5% in the last 3 years.
What is the current PB & PE ratio of Mono Pharmacare Ltd?
The P/E ratio of Mono Pharmacare Ltd is 45.05 times as on 31-Aug-2026, a 13 premium to its peers’ median range of 39.70 times.
The P/B ratio of Mono Pharmacare Ltd is 0.51 times as on 31-Aug-2026, a 86 discount to its peers’ median range of 3.72 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
13.21 |
1.31 |
2024 |
31.90 |
2.77 |
2023 |
0.00 |
0.00 |
2025 |
13.21 |
1.31 |
2024 |
31.90 |
2.77 |
What is the 52 Week High and Low of Mono Pharmacare Ltd?
The 52-week high and low of Mono Pharmacare Ltd are Rs 25.50 and Rs 7.50 as of 01-Sep-2026.
What is the market cap of Mono Pharmacare Ltd?
Mono Pharmacare Ltd has a market capitalisation of ₹ 16 Cr as on 31-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Mono Pharmacare Ltd?
Before investing in Mono Pharmacare Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.